Promethera Bio­sciences ap­points Mut­suki Takano as GM

BioSpectrum (Asia) - - People News -

Promethera Bio­sciences SA, a global in­no­va­tor in cell-based medicines and liver dis­eases, has an­nounced the ap­point­ment of Mut­suki Takano as Branch Gen­eral Man­ager of Promethera Bio­sciences Ja­pan Branch and Mem­ber of the Man­age­ment Team of Promethera Bio­sciences SA. As an­nounced in May 2018, Promethera’s branch office in Tokyo marks the start­ing point for build­ing a strong pres­ence of Promethera in Ja­pan and ad­di­tional Asian mar­kets. Mut­suki Takano joins Promethera from Mit­sui & Co., Ltd, one of the big­gest Ja­panese con­glom­er­ate where he was in­flu­en­tial in in­ter­na­tional busi­ness ac­tiv­i­ties such as new com­pany launches, the set-up of joint ven­tures, for­eign com­pany op­er­a­tions and re­struc­tur­ing projects in the US, UK, In­dia, China, and other Asian coun­tries. Most re­cently, his work fo­cused on pri­vate eq­uity trans­ac­tions in the biotech­nol­ogy sec­tor for Mit­sui Global In­vest­ment, the ven­ture cap­i­tal arm of Mit­sui & Co. Ltd. Mut­suki has con­trib­uted to the suc­cess­ful de­vel­op­ment of more than 10 port­fo­lio com­pa­nies as a board ob­server. He re­ceived a Bach­e­lor of Sci­ence in Pol­i­tics and Eco­nom­ics from the Waseda Univer­sity, Tokyo, Ja­pan and did his EMBA at Sun Yat-Sen Univer­sity, Guangzhou, China.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.